CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C308. A total of 60 filers reported holding CORMEDIX INC in Q1 2020. The put-call ratio across all filers is 9.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67 | -4.3% | 18,150 | +3.1% | 0.00% | – |
| Q2 2023 | $70 | -93.0% | 17,600 | +6467.2% | 0.00% | – |
| Q2 2022 | $1,000 | -99.2% | 268 | -98.9% | 0.00% | – |
| Q1 2022 | $129,000 | +20.6% | 23,518 | 0.0% | 0.00% | – |
| Q4 2021 | $107,000 | -2.7% | 23,518 | -0.3% | 0.00% | – |
| Q3 2021 | $110,000 | -31.7% | 23,581 | +0.5% | 0.00% | – |
| Q2 2021 | $161,000 | -30.6% | 23,464 | +1.1% | 0.00% | – |
| Q1 2021 | $232,000 | +45.9% | 23,200 | +8.4% | 0.00% | – |
| Q4 2020 | $159,000 | +80.7% | 21,400 | +46.6% | 0.00% | – |
| Q3 2020 | $88,000 | -4.3% | 14,600 | 0.0% | 0.00% | – |
| Q2 2020 | $92,000 | +76.9% | 14,600 | 0.0% | 0.00% | – |
| Q1 2020 | $52,000 | -50.9% | 14,600 | 0.0% | 0.00% | – |
| Q4 2019 | $106,000 | -31.2% | 14,600 | -39.4% | 0.00% | – |
| Q3 2019 | $154,000 | -28.7% | 24,100 | 0.0% | 0.00% | – |
| Q2 2019 | $216,000 | – | 24,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spinnaker Capital LLC | 175,384 | $649 | 100.00% |
| PLANNING DIRECTIONS INC | 50,000 | $185 | 0.14% |
| Castellan Group | 30,000 | $110,700 | 0.08% |
| Wick Capital Partners, LLC | 35,985 | $133,145 | 0.08% |
| GSG Advisors LLC | 30,000 | $111,000 | 0.05% |
| Elliott Investment Management L.P. | 1,550,523 | $5,736,935 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 74,763 | $276,623 | 0.04% |
| NOMURA HOLDINGS INC | 2,951,532 | $10,920,668 | 0.03% |
| American Financial Advisors, LLC | 30,527 | $112,950 | 0.02% |
| Advisor OS, LLC | 25,000 | $92,500 | 0.01% |